Similar articles

• Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.

  Wester RC, Maibach HI. Wester RC, et al. Drug Metab Rev. 1983;14(2):169-205. doi: 10.3109/03602538308991388. Drug Metab Rev. 1983. PMID: 6341024 Review. No abstract available.
• Modest but increased penetration through damaged skin: an overview of the in vivo human model.

  Gattu S, Maibach HI. Gattu S, et al. Skin Pharmacol Physiol. 2011;24(1):2-9. doi: 10.1159/000314995. Epub 2010 Jun 30. Skin Pharmacol Physiol. 2011. PMID: 20588085 Review.
• A multiple-pathway model for the diffusion of drugs in skin.

  Lee AJ, King JR, Rogers TG. Lee AJ, et al. IMA J Math Appl Med Biol. 1996 Jun;13(2):127-50. IMA J Math Appl Med Biol. 1996. PMID: 8671583
• Kinetics of cutaneous drug penetration.

  Franz TJ. Franz TJ. Int J Dermatol. 1983 Nov;22(9):499-505. doi: 10.1111/j.1365-4362.1983.tb02187.x. Int J Dermatol. 1983. PMID: 6358066 Review. No abstract available.
• Penetration properties and safety aspects of topically applied products.

  Fluhr J, Lademann J. Fluhr J, et al. Skin Pharmacol Physiol. 2008;21(6):293. doi: 10.1159/000162290. Epub 2008 Oct 10. Skin Pharmacol Physiol. 2008. PMID: 18997482 No abstract available.